Physician profile
Adenike A Adeleke
NPI 1235757014
$6,793.40
in general payments reported to CMS, 2019-2025
42 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what 83% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,098 · 2022: $2,383 · 2023: $490 · 2024: $653 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,312.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,172.53 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $1,085.90 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $669.87 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $464.58 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $436.25 | 2021-2025 | Caplyta |
| Neos Therapeutics, Lp | $264.44 | 2021-2023 | Adzenys Xr-Odt |
| Alkermes, INC. | $255.21 | 2021-2025 | Aristada, Lybalvi |
| Corium, LLC | $250.53 | 2021-2025 | Azstarys |
| Neurocrine Biosciences, INC. | $234.65 | 2021-2025 | |
| Beta Bionics, INC. | $195.98 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Janssen Pharmaceuticals, INC | $139.98 | 2022 | |
| Ironshore Pharmaceuticals INC. | $136.14 | 2021 | |
| Lundbeck LLC | $131.82 | 2021 | |
| Corcept Therapeutics | $125.24 | 2023-2025 | Korlym |
| Supernus Pharmaceuticals, INC. | $104.56 | 2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adenike Adeleke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.